Interpace Biosciences (IDXG) Stock Price
Interpace Biosciences Price
Revenue at Interpace Biosciences has contracted by 9.1% per year over the past 19 years to 38.73 M USD. Earnings per share have grown at 4.5% per year over the last 19 years. For Interpace Biosciences, the net margin of 63.5% is up versus -36.2% a few years ago. The consensus 12-month price target for Interpace Biosciences is 11.22 USD, about 87.0% above where the stock trades today. Of 7 analysts, 6 rate the stock a buy — an overall Buy consensus.
Interpace Biosciences stock price
Interpace Biosciences business model & stock analysis
Frequently asked questions about Interpace Biosciences
Analysts currently set an average price target of 11.22 USD for the Interpace Biosciences stock (median: 11.22 USD), implying +87.0 % versus the latest price. The consensus is based on 7 analyst ratings.
6 analysts currently rate the Interpace Biosciences stock: 0 recommend buying, 3 holding and 3 selling.
Converted at the current exchange rate, the Interpace Biosciences share trades at 5.35 EUR (6.00 USD).
The Interpace Biosciences share (IDXG) is listed on 4 stock exchanges, including: NASDAQ (IDXG), München (PF42.MU).
The revenue cannot currently be calculated for Interpace Biosciences.
The profit cannot currently be calculated for Interpace Biosciences.
The P/E ratio cannot be calculated for Interpace Biosciences at the moment.
The P/S cannot be calculated for Interpace Biosciences currently.
The Eulerpool Quality Score for Interpace Biosciences is 6/10.
The ISIN of Interpace Biosciences is US46062X3035. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Interpace Biosciences is A2PYCU. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Interpace Biosciences is IDXG. The ticker symbol is used to trade Interpace Biosciences shares on the stock exchange.
Interpace Biosciences stock
Interpace Biosciences Peer Group
Interpace Biosciences Ticker
Interpace Biosciences FIGI
All fundamentals and in-depth analysis of Interpace Biosciences
Our stock analysis for Interpace Biosciences stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Interpace Biosciences. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.